4.5 Article

Inhibitory effects of a maleimide compound on the virulence factors of Candida albicans

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Palmarumycin P3 Reverses Mrr1-Mediated Azole Resistance by Blocking the Efflux Pump Mdr1

Minghui Song et al.

Summary: Palmarumycin P3 can reverse azole resistance in Candida strains by reducing fluconazole-induced MDR1 transcription and restore susceptibility to several antifungal drugs. Additionally, PP3 inhibits the efflux of Mdr1 substrates by Candida strains with hyperactive MRR1 alleles.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Dentistry, Oral Surgery & Medicine

Effects of benzydamine and mouthwashes containing benzydamine on Candida albicans adhesion, biofilm formation, regrowth, and persistence

Andrea Ardizzoni et al.

Summary: This study demonstrates for the first time that benzydamine and mouthwashes containing benzydamine can affect Candida albicans biofilm formation and counteract biofilm persistence and regrowth.

CLINICAL ORAL INVESTIGATIONS (2022)

Article Immunology

Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms

Mengli Chen et al.

Summary: Candida albicans and Candida glabrata play critical roles in biofilm formation, and combination therapy with antifungal agents can effectively alleviate oropharyngeal candidiasis by inhibiting hyphal growth and reducing fungal burden in tissues.

VIRULENCE (2022)

Review Pharmacology & Pharmacy

Antimycotic Drugs and their Mechanisms of Resistance to Candida Species

Sweety Dahiya et al.

Summary: Fungal infections have been on the rise in recent decades, primarily due to the increase in immunocompromised patients. Invasive candidiasis is more common than invasive aspergillosis, with a mortality rate of around 45%. Ineffective diagnostic techniques and inappropriate initial treatment strategies contribute to this high mortality. There are only a few classes of antifungal drugs available for the treatment of invasive fungal infections, and the use of these drugs has increased significantly in the last few decades. However, this has also led to an increase in antifungal drug resistance, particularly to azoles. The emergence of antifungal drug resistance has resulted in reduced treatment success rates and major changes in the frequency of fungal infections.

CURRENT DRUG TARGETS (2022)

Review Pharmacology & Pharmacy

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action

Martin Hoenigl et al.

Summary: Infections caused by non-albicans Candida spp. are increasing, but the development of antifungal drugs is still progressing. The article discusses in detail the antifungal agents currently in clinical development for Candida, their mechanisms of action, and pharmacokinetic and pharmacodynamic properties. Expert opinions are provided on the potential roles of these investigational agents.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

Article Immunology

Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs

Pu Song et al.

Summary: This study investigated the effect of Candidalysin on mast cell (MC) activation and the underlying molecular mechanism. The results showed that Candidalysin enhanced MC degranulation, migration, and production of cytokines, eicosanoids, and reactive oxygen species. Additionally, Candidalysin increased the expression of Dectin-1, and inhibiting Dectin-1 reduced MC activation.

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Article Oncology

Antifungal effect of a new photosensitizer derived from BODIPY on Candida albicans biofilms

Mengran Wang et al.

Summary: This study found that photodynamic therapy mediated by a new photosensitizer derived from BODIPY exhibited a favorable antifungal effect on C. albicans biofilms.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2022)

Article Microbiology

Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans

Leandro Honorato et al.

Summary: This study investigates the impact of fungal extracellular vesicles (EVs) on biofilm formation and virulence in Candida albicans. The researchers found that C. albicans EVs inhibit biofilm formation and promote pseudohyphae formation. EVs from different strains of C. albicans, S. cerevisiae, and H. capsulatum also inhibit yeast-to-hyphae differentiation. The inhibitory effect of C. albicans EVs is attributed to a combination of lipid compounds.
Article Microbiology

Selective Metal Chelation by a Thiosemicarbazone Derivative Interferes with Mitochondrial Respiration and Ribosome Biogenesis in Candida albicans

Ximeng Duan et al.

Summary: In this study, a thiosemicarbazone derivative 19ak is shown to selectively inhibit mitochondrial respiration and ribosome biogenesis in C. albicans by chelating iron and disrupting intracellular zinc homeostasis, resulting in broad-spectrum antifungal activity with minimal cytotoxicity, low capacity to induce resistance, and in vivo efficacy.

MICROBIOLOGY SPECTRUM (2022)

Article Medical Laboratory Technology

Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients

Bo Wang et al.

Summary: This study investigated the species distribution, antifungal sensitivities, clinical characteristics, and risk factors of critically ill patients with invasive Candida infections. The results showed that Candida albicans was the predominant species, and resistance to fluconazole was the highest among Candida spp.

CLINICAL LABORATORY (2022)

Article Chemistry, Medicinal

Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation

Yunfei An et al.

Summary: Fungal infections have become a serious medical problem due to high infection rates and drug resistance. This study identified active compounds with binding ability to dual targets, synthesized target compounds with antifungal activity, some of which showed broad-spectrum antifungal properties and significant effects against drug-resistant fungi.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biotechnology & Applied Microbiology

Antibiofilm and antifungal activities of medium-chain fatty acids against Candida albicans via mimicking of the quorum-sensing molecule farnesol

Jin-Hyung Lee et al.

Summary: Medium-chain fatty acids were found to effectively inhibit hyphal growth and biofilm formation of Candida albicans, surpassing the inhibitory effects of farnesol.

MICROBIAL BIOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Coordination of fungal biofilm development by extracellular vesicle cargo

Robert Zarnowski et al.

Summary: The fungal pathogen Candida albicans can form biofilms that protect it from drugs and the immune system by releasing extracellular vesicles (EVs) that promote extracellular matrix formation and resistance to antifungal drugs. The study identifies functions for numerous EV cargo proteins in biofilm matrix assembly, drug resistance, fungal cell adhesion, and dissemination. The findings suggest that EVs play a crucial role in coordinating biofilm development in C. albicans.

NATURE COMMUNICATIONS (2021)

Correction Biotechnology & Applied Microbiology

Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins (vol 5, 21, 2019)

Andrew D. McCall et al.

NPJ BIOFILMS AND MICROBIOMES (2021)

Review Genetics & Heredity

The Complex Genetic Basis and Multilayered Regulatory Control of Yeast Pseudohyphal Growth

Anuj Kumar

Summary: Eukaryotic cells exhibit precise control over diverse growth processes through complex regulatory mechanisms. The budding yeast Saccharomyces cerevisiae serves as an interesting model for cell growth, particularly in its stress-responsive transition to filamentous pseudohyphal growth. This transition has been extensively studied as a model for conserved signaling pathways regulating cell growth and for understanding the pathogenicity of the opportunistic fungus Candida albicans.

ANNUAL REVIEW OF GENETICS, VOL 55 (2021)

Article Immunology

Candidemia and Invasive Candidiasis

Todd P. McCarty et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2021)

Article Immunology

Lichen Polyphenolic Compounds for the Eradication of Candida albicans Biofilms

Marion Girardot et al.

Summary: Lichens, with their symbiotic nature of fungi and algae, produce unique polyphenolic compounds that show potential anti-biofilm activity against Candida albicans. Among these compounds, evernic acid stands out as an effective inhibitor of biofilm formation and maturation, showing low toxicity and no hemolytic activity at active concentrations.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

BbWor1, a Regulator of Morphological Transition, Is Involved in Conidium-Hypha Switching, Blastospore Propagation, and Virulence in Beauveria bassiana

Lei Qiu et al.

Summary: The research identified BbWor1 as a core transcription factor that regulates the production of conidia and blastospores, as well as hyphal growth. BbWor1 affects fungal pathogenicity and the global transcription profiles within three models of growth stage transformation.

MICROBIOLOGY SPECTRUM (2021)

Article Microbiology

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris

Fruzsina Nagy et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Plant Sciences

Boesenbergia rotunda extract inhibits Candida albicans biofilm formation by pinostrobin and pinocembrin

Jamras Kanchanapiboon et al.

JOURNAL OF ETHNOPHARMACOLOGY (2020)

Article Infectious Diseases

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

Francesca Gioia et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Review Immunology

The regulation of hyphae growth in Candida albicans

Hui Chen et al.

VIRULENCE (2020)

Review Infectious Diseases

Resistance of Candida to azoles and echinocandins worldwide

K. E. Pristov et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

Review Biochemistry & Molecular Biology

Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans

Guanghua Huang et al.

MOLECULAR MICROBIOLOGY (2019)

Review Microbiology

Candida auris: a Review of the Literature

Anna Jeffery-Smith et al.

CLINICAL MICROBIOLOGY REVIEWS (2018)

Article Microbiology

Candida albicans infection and intestinal immunity

Yiqing Tong et al.

MICROBIOLOGICAL RESEARCH (2017)

Article Microbiology

In Vitro Antibiofilm Activity of Eucarobustol E against Candida albicans

Rui-Huan Liu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Review Medicine, General & Internal

Candidemia and invasive candidiasis in adults: A narrative review

Spinello Antinori et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)

Editorial Material Multidisciplinary Sciences

MICROBIOLOGY Fungus produces a toxic surprise

Aaron P. Mitchell

NATURE (2016)

Article Microbiology

The lipopeptides pseudofactin II and surfactin effectively decrease Candida albicans adhesion and hydrophobicity

Piotr Biniarz et al.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2015)

Article Biotechnology & Applied Microbiology

Natural product solasodine-3-Ο-β-D-glucopyranoside inhibits the virulence factors of Candida albicans

Ying Li et al.

FEMS YEAST RESEARCH (2015)

Review Immunology

Candida albicans pathogenicity mechanisms

Francois L. Mayer et al.

VIRULENCE (2013)

Article Pharmacology & Pharmacy

Retigeric Acid B Enhances the Efficacy of Azoles Combating the Virulence and Biofilm Formation of Candida albicans

Wenqiang Chang et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)

Review Immunology

Candida albicans interactions with epithelial cells and mucosal immunity

Julian R. Naglik et al.

MICROBES AND INFECTION (2011)

Article Chemistry, Multidisciplinary

Effect of plagiochin E, an antifungal macrocyclic bis(bibenzyl), on cell wall chitin synthesis in Candida albicans

Xiu-zhen Wu et al.

ACTA PHARMACOLOGICA SINICA (2008)

Article Biochemistry & Molecular Biology

N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: Time-to-kill, stability, interaction with maleamic acids

Maximillano Sortino et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Immunology

Protective effects of farnesol against oral candidiasis in mice

Tatsuya Hisajima et al.

MICROBIOLOGY AND IMMUNOLOGY (2008)

Review Cell Biology

Genetics and genomics of Candida albicans biofilm formation

Clarissa J. Nobile et al.

CELLULAR MICROBIOLOGY (2006)

Article Biotechnology & Applied Microbiology

Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum

DD Mosel et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)

Article Microbiology

Farnesol biosynthesis in Candida albicans:: Cellular response to sterol inhibition by zaragozic acid B

JM Hornby et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

Article Biochemistry & Molecular Biology

Candida albicans Als1p:: an adhesin that is a downstream effector of the EFG1 filamentation pathway

Y Fu et al.

MOLECULAR MICROBIOLOGY (2002)